Earning Reports
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Asset Management
WhiteHorse Finance Inc (WHF) Q2 2024 Earnings: EPS of $0.40 Misses Estimates, Revenue of $23.48M Falls Short
WhiteHorse Finance Inc (WHF) released its 8-K filing on August 8, 2024, detailing its financial performance for the quarter ended June 30, 2024. Aug 08, 2024
GuruFocus Research Biotechnology
Immunocore Holdings PLC (IMCR) Q2 2024 Earnings: EPS Loss of $0.23, Revenue Surpasses Estimates at $75.3 Million
Immunocore Holdings PLC (IMCR) released its 8-K filing on August 8, 2024, detailing its financial performance for the second quarter ended June 30, 2024. Aug 08, 2024
GuruFocus Research Biotechnology
Monte Rosa Therapeutics Inc (GLUE) Q2 2024 Earnings: EPS of -$0.43 Beats Estimates, Revenue of $4.7 Million Exceeds Expectations
Monte Rosa Therapeutics Inc (GLUE) released its 8-K filing on August 8, 2024, detailing its second-quarter financial results and corporate updates. Aug 08, 2024